Pricey pills for an even pricier problem. - Wikidata - wikimedia - TriplyDB

Pricey pills for an even pricier problem.

Pricey pills for an even pricier problem.

http://www.wikidata.org/entity/Q36751083

about

Pricey pills for an even pricier problem.

http://www.wikidata.org/entity/Q36751083

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pricey pills for an even pricier problem.

@en

type

label

Pricey pills for an even pricier problem.

@en

prefLabel

Pricey pills for an even pricier problem.

@en

P1433

Q36751083-5CD0C67C-33C4-416F-A407-E274D66F1F48

P1476

Q36751083-971C9184-4366-4601-9766-5B471C63368A

P2093

Q36751083-6C22064A-D416-41A2-B053-C16264483416

P2860

Q36751083-08405343-6955-488C-9E69-BAEBF6210824

Q36751083-0F5FF2A4-A978-47B3-9CE3-903A7B62536D

Q36751083-20547C9B-C2E0-4C89-9D29-878CF2452E76

Q36751083-61B61B06-0F4E-40CB-A678-857D48EF0547

Q36751083-7C4B98F0-9516-45F3-97FF-123FD1565C0A

Q36751083-8C3F57FB-5B1D-4F03-86D6-EBA7D88CB4CA

Q36751083-9399809C-4000-4701-B73B-B8095CD4EBB8

Q36751083-C7261939-8B05-48B2-9DC9-759A3C99D6FD

Q36751083-CC4B99AF-8CEF-4070-87B7-8F77D8E93022

Q36751083-D58C981F-8B16-4038-AD87-7AA7B34329C9

P304

Q36751083-13DA26E3-A466-480E-B931-B6385A6E9928

P31

Q36751083-699DAF64-8AD7-41D7-BA8A-05C5F901FF8F

Q36751083-bba092cc-cca1-4508-97e6-ef04438e9a23

P356

Q36751083-12015CF1-532C-4AF2-88CE-E90F250C2825

P407

Q36751083-51117A41-4C32-4E9C-AB29-AFE14260D9D7

P433

Q36751083-931A791D-E8DA-40DB-B77B-521D1AD4FDE1

P478

Q36751083-B6D20A0D-1B7D-4DF1-8679-EAB8E071D185

P577

Q36751083-507E1965-3F72-4C2C-9A5B-0FCEDE6F409D

P698

Q36751083-BDE4140D-3F81-4863-92E5-8CB27C404873

P932

Q36751083-DF60EA90-F3B5-470A-9935-209896702932

P356

P1433

P1476

Pricey pills for an even pricier problem.

@en

P2093

Sharon W Kwan

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of viral hepatitis and hepatocellular carcinoma

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis.

Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States

Chronic hepatitis C virus (HCV) disease burden and cost in the United States.

All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective.

Comparative Clinical Effectiveness and Value of Novel Interferon-Free Combination Therapy for Hepatitis C Genotype 1: Summary of California Technology Assessment Forum Report.

Health care costs associated with hepatocellular carcinoma: a population-based study.

P304

840-841

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.29854

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26716603

http://www.w3.org/2001/XMLSchema#string

P932

4815917

http://www.w3.org/2001/XMLSchema#string